Results of loss-of-function experiments revealed that the knockdown of DSCAM-AS1 in CRC cells can inhibit migration, cell proliferation, and invasion in vitro, as well as cause suppression of tumor growth in vivo, which suggests that DSCAM-AS1 function is required for CRC progression. This evidence concerns the gene DSCAM and colorectal carcinoma.